drugset / Trial / NCT00210366
Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The main objective of the trial is to assess the therapeutic activity of idarubicin as salvage treatment in patients with recurrent or progressive lymphoma in the central nervous system.
Timeline
- Start
- 2004-11
- Primary completion
- 2010-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Idarubicin | Small molecule | — | — |